Skip to main content
NCBI home page
British Heart Journal logoLink to British Heart Journal
. 1979 Nov;42(5):587–594. doi: 10.1136/hrt.42.5.587

Haemodynamic effects of disopyramide in patients after open-heart surgery.

N Naqvi, D S Thompson, W E Morgan, B T Williams, D J Coltart
PMCID: PMC482205  PMID: 316334

Abstract

Disopyramide phosphate was administered intravenously in a dose of 1.2 mg/kg body weight over one minute to nine patients after open-heart surgery and coronary artery bypass grafting. The haemodynamic changes were studied during and for 30 minutes after drug administration. Heart rate was unchanged throughout the study. During infusion the only significant changes were an increase in systemic blood pressure and systolic impedance signifying a direct increase in peripheral arterial resistance. Systemic blood pressure remained significantly higher for 10 minutes and systolic impedance for 30 minutes. Immediately after infusion max. dPower/dT, a measure of ventricular contractility, was significantly depressed for 15 minutes. Both cardiac output and aortic flow were significantly depressed for 30 minutes. DPTI/TTI, an estimate of subendocardial supply/demand ratio, showed an insignificant increase throughout the study. This study shows that intravenous disopyramide starts acting within 45 seconds of the start of infusion, directly increases peripheral arterial resistance, has a breif negative inotropic action, and does not reduce subendocardial blood flow.

Full text

PDF
587

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Befeler B. The hemodynamic effects of Norpace (Part I). Angiology. 1975 Jan;26(1 Pt 2):99–101. [PubMed] [Google Scholar]
  2. Bourne P. R., Williams B. T. A cardiac monitor combining flow and pressure measurement. Biomed Eng. 1975 Dec;10(12):453–455. [PubMed] [Google Scholar]
  3. Buckberg G. D., Fixler D. E., Archie J. P., Hoffman J. I. Experimental subendocardial ischemia in dogs with normal coronary arteries. Circ Res. 1972 Jan;30(1):67–81. doi: 10.1161/01.res.30.1.67. [DOI] [PubMed] [Google Scholar]
  4. Deano D. A., Wu D., Mautner R. K., Sherman R. H., Ehsani A. I., Rosen K. M. The antiarrhythmic efficacy of intravenous therapy with disopyramide phosphate. Chest. 1977 May;71(5):597–606. doi: 10.1378/chest.71.5.597. [DOI] [PubMed] [Google Scholar]
  5. Farnsworth A. E., Angerpointner T. A., Lewis G. J., Bourne P. R., Williams B. T. A monitor for the continuous assessment of left ventricular performance after open-heart operations. Ann Thorac Surg. 1977 Feb;23(2):169–172. doi: 10.1016/s0003-4975(10)64095-7. [DOI] [PubMed] [Google Scholar]
  6. Hillis W. S., Tweddel A., Lorimer A. R., Lawrie T. D. Some aspects of the clinical pharmacology of intravenous disopyramide after myocardial infarction. J Int Med Res. 1976;4(1 Suppl):74–77. [PubMed] [Google Scholar]
  7. Hoffman J. I., Buckberg G. D. Pathophysiology of subendocardial ischaemia. Br Med J. 1975 Jan 11;1(5949):76–79. doi: 10.1136/bmj.1.5949.76. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Hoffman J. I., Buckberg G. D. The myocardial supply:demand ratio--a critical review. Am J Cardiol. 1978 Feb;41(2):327–332. doi: 10.1016/0002-9149(78)90174-1. [DOI] [PubMed] [Google Scholar]
  9. Hulting J., Rosenhamer G. Hemodynamic and electrocardiographic effects of disopyramide in patients with ventricular arrhythmia. Acta Med Scand. 1976;199(1-2):41–51. doi: 10.1111/j.0954-6820.1976.tb06689.x. [DOI] [PubMed] [Google Scholar]
  10. Hutsell T. C., Stachelski S. J. Determination of disopyramide and its mono-N-dealkylated metabolite in blood serum and urine. J Chromatogr. 1975 Mar 19;106(1):151–158. doi: 10.1016/s0021-9673(01)81057-8. [DOI] [PubMed] [Google Scholar]
  11. Jenkins B. S., Branthwaite M. A., Bradley R. D. Cardiac function after open heart surgery. Relation between the performance of the two sides of the heart. Cardiovasc Res. 1973 May;7(3):297–305. doi: 10.1093/cvr/7.3.297. [DOI] [PubMed] [Google Scholar]
  12. Jennings G., Jones M. S., Besterman E. M., Model D. G., Turner P. P., Kidner P. H. Oral disopyramide in prophylaxis of arrhythmias following myocardial infarction. Lancet. 1976 Jan 10;1(7950):51–54. doi: 10.1016/s0140-6736(76)90148-3. [DOI] [PubMed] [Google Scholar]
  13. Jensen G., Sigurd B., Uhrenholt A. Haemodynamic effects of intravenous disopyramide in heart failure. Eur J Clin Pharmacol. 1975 Apr 4;8(3-4):167–173. doi: 10.1007/BF00567110. [DOI] [PubMed] [Google Scholar]
  14. Karim A. The pharmacokinetics of Norpace. Angiology. 1975 Jan;26(1 Pt 2):85–98. [PubMed] [Google Scholar]
  15. Lewis G. J., Poole-Wilson P. A., Angerpointer T., Coltart D. J., Williams B. T. Use of electromagnetic flow probes to assess myocardial performance in man. Eur J Cardiol. 1978 Jun;7(4):283–292. [PubMed] [Google Scholar]
  16. MOKLER C. M., VAN ARMAN C. G. Pharmacology of a new antiarrhythmic agent, gamma-diisopropyl-amino-alpha-phenyl-alpha-(2-pyridyl)-butyramide (SC-7031). J Pharmacol Exp Ther. 1962 Apr;136:114–124. [PubMed] [Google Scholar]
  17. Marrott P. K., Ruttley M. S., Winterbottam J. T., Muir J. R. A study of the acute electrophysiological and cardiovascular action of disopyramide in man. Eur J Cardiol. 1976 Sep;4(3):303–312. [PubMed] [Google Scholar]
  18. Mathur P. P. Cardiovascular effects of a newer antiarrhythmic agent, disopyramide phosphate. Am Heart J. 1972 Dec;84(6):764–770. doi: 10.1016/0002-8703(72)90069-5. [DOI] [PubMed] [Google Scholar]
  19. McHaffie D. J., Guz A., Johnston A. Impotence in patient on disopyramide. Lancet. 1977 Apr 16;1(8016):859–859. doi: 10.1016/s0140-6736(77)92811-2. [DOI] [PubMed] [Google Scholar]
  20. Milnor W. R. Arterial impedance as ventricular afterload. Circ Res. 1975 May;36(5):565–570. doi: 10.1161/01.res.36.5.565. [DOI] [PubMed] [Google Scholar]
  21. Mizgala H. F., Huvelle P. R. Acute termination of cardiac arrhythmias with intravenous disopyramide. J Int Med Res. 1976;4(1 Suppl):82–85. [PubMed] [Google Scholar]
  22. Niarchos A. P. Disopyramide: serum level and arrhythmia conversion. Am Heart J. 1976 Jul;92(1):57–64. doi: 10.1016/s0002-8703(76)80403-6. [DOI] [PubMed] [Google Scholar]
  24. Rangno R. E., Warnica W., Ogilvie R. I., Kreeft J., Bridger E. Correlation of disopyramide pharmacokinetics with efficacy in ventricular tachyarrhythmia. J Int Med Res. 1976;4(1 Suppl):54–58. [PubMed] [Google Scholar]
  25. Slogoff S., Keats A. S., Hibbs C. W., Edmonds C. H., Bragg D. A. Failure of general anesthesia to potentiate propranolol activity. Anesthesiology. 1977 Dec;47(6):504–508. doi: 10.1097/00000542-197712000-00006. [DOI] [PubMed] [Google Scholar]
  26. Spurrell R. A., Thorburn C. W., Camm J., Sowton E., Deuchar D. C. Effects of disopyramide on electrophysiological properties of specialized conduction system in man and on accessory atrioventricular pathway in Wolff-Parkinson-White syndrome. Br Heart J. 1975 Aug;37(8):861–867. doi: 10.1136/hrt.37.8.861. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Stein P. D., Sabbah H. N. Rate of change of ventricular power: an indicator of ventricular performance during ejection. Am Heart J. 1976 Feb;91(2):219–227. doi: 10.1016/s0002-8703(76)80577-7. [DOI] [PubMed] [Google Scholar]
  28. Trope G. E., Hind V. M. Closed-angle glaucoma in patient on disopyramide. Lancet. 1978 Feb 11;1(8059):329–329. doi: 10.1016/s0140-6736(78)90102-2. [DOI] [PubMed] [Google Scholar]
  29. Vismara L. A., Mason D. T., Amsterdam E. A. Disopyramide phosphate: clinical efficacy of a new oral antiarrhythmic drug. Clin Pharmacol Ther. 1974 Aug;16(2):330–335. doi: 10.1002/cpt1974162330. [DOI] [PubMed] [Google Scholar]
  30. Whiting B., Elliott H. L. Disopyramide in renal impairment. Lancet. 1977 Dec 24;2(8052-8053):1363–1363. doi: 10.1016/s0140-6736(77)90418-4. [DOI] [PubMed] [Google Scholar]
  31. Williams B. T., Sancho-Fornos S., Clarke D. B., Abrams L. D., Schenk W. G., Jr, Barefoot C. A. The Williams-Barefoot extractable blood flow probe. Design, transducer characteristics, and clinical application in cardiac surgery. J Thorac Cardiovasc Surg. 1972 Jun;63(6):917–921. [PubMed] [Google Scholar]

Articles from British Heart Journal are provided here courtesy of BMJ Publishing Group

RESOURCES